Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neus Villamor

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
Current Protocols in Cytometry|September 5, 2008
ZAP-70 staining in chronic lymphocytic leukemiaNeus Villamor
Current Pharmaceutical Design|March 26, 2004
Cytotoxic effects of B lymphocytes mediated by reactive oxygen speciesNeus Villamor, Emili Montserrat, Dolors Colomer
Seminars in Oncology|August 27, 2003
Mechanism of action and resistance to monoclonal antibody therapyNeus Villamor, Emili Montserrat, Dolors Colomer
Best Practice & Research. Clinical Haematology|October 16, 2016
Genetic evolution in chronic lymphocytic leukaemiaJulio Delgado, Neus Villamor, Armando López-Guillermo, et al.
Seminars in Hematology|November 20, 2013
Next-generation sequencing in chronic lymphocytic leukemiaNeus Villamor, Armando López-Guillermo, Carlos López-Otín, et al.
Blood|January 18, 2007
The BH3-mimetic GX15-070 synergizes with bortezomib in mantle cell lymphoma by enhancing Noxa-mediated activation of BakPatricia Pérez-Galán, Gaël Roué, Neus Villamor, et al.
Haematologica|September 2, 2014
Survival analysis in hematologic malignancies: recommendations for cliniciansJulio Delgado, Arturo Pereira, Neus Villamor, et al.
Current Oncology (Toronto, Ont.)|June 27, 2023
Novel Tools for Diagnosis and Monitoring of AMLFrancesca Guijarro, Marta Garrote, Neus Villamor, et al.
Blood|September 17, 2005
The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 statusPatricia Pérez-Galán, Gaël Roué, Neus Villamor, et al.
Cytometry. Part B, Clinical Cytometry|October 29, 2003
Routine use of immunophenotype by flow cytometry in tissues with suspected hematological malignanciesAntoni Martínez, Marta Aymerich, Mireia Castillo, et al.
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
Current Protocols in Cytometry|September 5, 2008
ZAP-70 staining in chronic lymphocytic leukemiaNeus Villamor
Current Pharmaceutical Design|March 26, 2004
Cytotoxic effects of B lymphocytes mediated by reactive oxygen speciesNeus Villamor, Emili Montserrat, Dolors Colomer
Seminars in Oncology|August 27, 2003
Mechanism of action and resistance to monoclonal antibody therapyNeus Villamor, Emili Montserrat, Dolors Colomer
Best Practice & Research. Clinical Haematology|October 16, 2016
Genetic evolution in chronic lymphocytic leukaemiaJulio Delgado, Neus Villamor, Armando López-Guillermo, et al.
Seminars in Hematology|November 20, 2013
Next-generation sequencing in chronic lymphocytic leukemiaNeus Villamor, Armando López-Guillermo, Carlos López-Otín, et al.
Blood|January 18, 2007
The BH3-mimetic GX15-070 synergizes with bortezomib in mantle cell lymphoma by enhancing Noxa-mediated activation of BakPatricia Pérez-Galán, Gaël Roué, Neus Villamor, et al.
Haematologica|September 2, 2014
Survival analysis in hematologic malignancies: recommendations for cliniciansJulio Delgado, Arturo Pereira, Neus Villamor, et al.
Current Oncology (Toronto, Ont.)|June 27, 2023
Novel Tools for Diagnosis and Monitoring of AMLFrancesca Guijarro, Marta Garrote, Neus Villamor, et al.
Blood|September 17, 2005
The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 statusPatricia Pérez-Galán, Gaël Roué, Neus Villamor, et al.
Cytometry. Part B, Clinical Cytometry|October 29, 2003
Routine use of immunophenotype by flow cytometry in tissues with suspected hematological malignanciesAntoni Martínez, Marta Aymerich, Mireia Castillo, et al.
Pageof 14